189 related articles for article (PubMed ID: 34961421)
21.
Yazaki K
Plant Biotechnol (Tokyo); 2017; 34(3):131-142. PubMed ID: 31275019
[No Abstract] [Full Text] [Related]
22. Characterization of Arnebia euchroma PGT homologs involved in the biosynthesis of shikonin.
Wang S; Shi L; Wang R; Liu C; Wang J; Shen Y; Tatsumi K; Navrot N; Liu T; Guo L
Plant Physiol Biochem; 2023 Mar; 196():587-595. PubMed ID: 36780721
[TBL] [Abstract][Full Text] [Related]
23. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice.
Lee HJ; Lee HJ; Magesh V; Nam D; Lee EO; Ahn KS; Jung MH; Ahn KS; Kim DK; Kim JY; Kim SH
Yakugaku Zasshi; 2008 Nov; 128(11):1681-8. PubMed ID: 18981704
[TBL] [Abstract][Full Text] [Related]
24. Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.
Huang WR; Zhang Y; Tang X
Molecules; 2014 Jun; 19(6):7785-97. PubMed ID: 24962386
[TBL] [Abstract][Full Text] [Related]
25. Transgenic analysis reveals LeACS-1 as a positive regulator of ethylene-induced shikonin biosynthesis in Lithospermum erythrorhizon hairy roots.
Fang R; Wu F; Zou A; Zhu Y; Zhao H; Zhao H; Liao Y; Tang RJ; Yang T; Pang Y; Wang X; Yang R; Qi J; Lu G; Yang Y
Plant Mol Biol; 2016 Mar; 90(4-5):345-58. PubMed ID: 26780904
[TBL] [Abstract][Full Text] [Related]
26. Comparative Proteomic Analysis of Lithospermum erythrorhizon Reveals Regulation of a Variety of Metabolic Enzymes Leading to Comprehensive Understanding of the Shikonin Biosynthetic Pathway.
Takanashi K; Nakagawa Y; Aburaya S; Kaminade K; Aoki W; Saida-Munakata Y; Sugiyama A; Ueda M; Yazaki K
Plant Cell Physiol; 2019 Jan; 60(1):19-28. PubMed ID: 30169873
[TBL] [Abstract][Full Text] [Related]
27. Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches.
Sun Q; Gong T; Liu M; Ren S; Yang H; Zeng S; Zhao H; Chen L; Ming T; Meng X; Xu H
Phytomedicine; 2022 Jan; 94():153805. PubMed ID: 34749177
[TBL] [Abstract][Full Text] [Related]
28. Transgenic studies reveal the positive role of LeEIL-1 in regulating shikonin biosynthesis in Lithospermum erythrorhizon hairy roots.
Fang R; Zou A; Zhao H; Wu F; Zhu Y; Zhao H; Liao Y; Tang RJ; Pang Y; Yang R; Wang X; Qi J; Lu G; Yang Y
BMC Plant Biol; 2016 May; 16(1):121. PubMed ID: 27230755
[TBL] [Abstract][Full Text] [Related]
29. Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro.
Gao H; Liu L; Qu ZY; Wei FX; Wang SQ; Chen G; Qin L; Jiang FY; Wang YC; Shang L; Gao CY
Biol Pharm Bull; 2011; 34(2):197-202. PubMed ID: 21415527
[TBL] [Abstract][Full Text] [Related]
30. Preparative high-speed counter-current chromatography for purification of shikonin from the Chinese medicinal plant Lithospermum erythrorhizon.
Lu HT; Jiang Y; Chen F
J Chromatogr A; 2004 Jan; 1023(1):159-63. PubMed ID: 14760860
[TBL] [Abstract][Full Text] [Related]
31. Shikonin and its derivatives: a patent review.
Wang R; Yin R; Zhou W; Xu D; Li S
Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
[TBL] [Abstract][Full Text] [Related]
32. Shikonin ameliorates isoproterenol (ISO)-induced myocardial damage through suppressing fibrosis, inflammation, apoptosis and ER stress.
Yang J; Wang Z; Chen DL
Biomed Pharmacother; 2017 Sep; 93():1343-1357. PubMed ID: 28753907
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological function and evaluation of Shikonin in cancer therapy.
Wang F; Yao X; Zhang Y; Tang J
Fitoterapia; 2019 Apr; 134():329-339. PubMed ID: 30858045
[TBL] [Abstract][Full Text] [Related]
34. Shikonin derivatives for cancer prevention and therapy.
Boulos JC; Rahama M; Hegazy MF; Efferth T
Cancer Lett; 2019 Sep; 459():248-267. PubMed ID: 31132429
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.
Guo Y; Zhou M; Mu Z; Guo J; Hou Y; Xu Y; Geng L
Biomed Pharmacother; 2023 Sep; 165():115138. PubMed ID: 37454591
[TBL] [Abstract][Full Text] [Related]
36. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
[TBL] [Abstract][Full Text] [Related]
37. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
39. Shikonin inhibits TNF-α production through suppressing PKC-NF-κB-dependent decrease of IL-10 in rheumatoid arthritis-like cell model.
Sun WX; Liu Y; Zhou W; Li HW; Yang J; Chen ZB
J Nat Med; 2017 Apr; 71(2):349-356. PubMed ID: 27943122
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory Effects of Shikonin Dispersion, an Extract of
Nomura R; Suehiro Y; Tojo F; Matayoshi S; Okawa R; Hamada M; Naka S; Matsumoto-Nakano M; Unesaki R; Koumoto K; Kawauchi K; Nishikata T; Akitomo T; Mitsuhata C; Yagi M; Mizoguchi T; Fujikawa K; Taniguchi T; Nakano K
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
